Lamivudine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
31722-754 -
Package NDC
31722-754-06 -
Package NDC
31722-754-30 -
Package NDC
31722-754-31 -
Package NDC
31722-754-32 -
Application number
ANDA203277 -
SPL ID
2b44b10b-132c-4593-e063-6294a90a3ffd -
SPL set ID
49d53e74-3798-4463-b817-1c8beb755034 -
UNII
2T8Q726O95 -
RxCUI
199147 -
RxCUI
349491
What the source publishes
- Labeler
- Camber Pharmaceuticals, Inc.
- Active ingredients
- Lamivudine
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Lamivudine",
"splId": "2b44b10b-132c-4593-e063-6294a90a3ffd",
"labels": [
{
"setId": "49d53e74-3798-4463-b817-1c8beb755034",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49d53e74-3798-4463-b817-1c8beb755034",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=49d53e74-3798-4463-b817-1c8beb755034"
}
],
"routes": [
"ORAL"
],
"labeler": "Camber Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "600 TABLET, FILM COATED in 1 BOTTLE (31722-754-06)",
"package_ndc": "31722-754-06",
"identifierStatus": "well-formed",
"marketing_start_date": "20140106"
},
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (31722-754-30)",
"package_ndc": "31722-754-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20140106"
},
{
"sample": false,
"description": "10 TABLET, FILM COATED in 1 BLISTER PACK (31722-754-31)",
"package_ndc": "31722-754-31",
"identifierStatus": "well-formed",
"marketing_start_date": "20140106"
},
{
"sample": false,
"description": "100 TABLET, FILM COATED in 1 CARTON (31722-754-32)",
"package_ndc": "31722-754-32",
"identifierStatus": "well-formed",
"marketing_start_date": "20140106"
}
],
"productId": "31722-754_2b44b10b-132c-4593-e063-6294a90a3ffd",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "31722-754",
"deaSchedule": null,
"genericName": "Lamivudine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LAMIVUDINE",
"strength": "300 mg/1"
}
],
"applicationNumber": "ANDA203277",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20140106",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175656",
"N0000175462",
"N0000009947"
],
"unii": [
"2T8Q726O95"
],
"rxcui": [
"199147",
"349491"
],
"spl_set_id": [
"49d53e74-3798-4463-b817-1c8beb755034"
],
"pharm_class_epc": [
"Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Nucleoside Reverse Transcriptase Inhibitors [MoA]"
],
"manufacturer_name": [
"Camber Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:31722-754_2b44b10b-132c-4593-e063-6294a90a3ffd"